Salmonella typhimurium X4064, an attenuated Acya Acrp mutant of S. typhimurium SR-11, was shown to be avirulent in swine. S. typhimurium X4064 was used as a carrier for plasmid pBA31-R7, which codes for the expression of a 31-kDa protein from Brucella abortus (BCSP31). Given orally, S. typhimurium X4064(pBA31-R7) colonized the intestine and mesenteric lymph nodes of 5-to 6-week-old crossbred swine. Orally immunized animals developed serum and intestinal antibody responses to the B. abortus 31-kDa protein and to salmonella endotoxin as measured by enzyme-linked immunosorbent assay. Similarly immunized swine did not develop delayed-type hypersensitivity following a subcutaneous injection of recombinant BCSP31. However, swine parenteraHly immunized with recombinant BCSP31 incorporated in Freund incomplete adjuvant did develop a delayed-type hypersensitivity response to the homologous antigen. The data indicated that oral presentation of antigen to swine in the context of recombinant S. typhimurium effectively stimulated mucosal and systemic antibody-mediated immunity but failed to sensitize swine for either an antigen-specific delayed-type hypersensitivity or a blastogenic response to the cloned BCSP31.
Live vaccine strains such as Salmonella typhimurium may play an important future role as carriers for protective antigens from other pathogenic organisms. Theoretically, these vaccines must stimulate a humoral or cell-mediated immune response to the appropriate pathogen at the site of infection or microbial replication (7) . To achieve protection against naturally occurring mucosal infections, oral vaccination with a live recombinant organism may be necessary. Much of the difficulty in developing protocols for oral immunization has involved the delivery of sufficient antigen to immunize the host effectively without development of oral tolerance (16) . Since S. typhimurium naturally invades and persists in gut-associated lymphoid tissue (3, 8, 24) , this organism delivers antigen directly to the mucosal surface (4, 13, 14, 23) , where it can stimulate secretory, humoral, and cellular immune responses (2, 4, 11, 19) .
The present study examines the capabilities of S. typhimurium X4064 (Acya Acrp) to serve as a vehicle for delivery of a cloned antigen to the porcine immune system. This strain has retained its ability to colonize and invade murine Peyer's patches and has been shown to induce protection in mice against a lethal challenge of parent strain S. typhimurium SR-11 (5). Mayfield et al. (15) have recently cloned the gene for a Brucella abortus 31-kDa protein (BCSP31) into Escherichia coli K-12. The plasmid (pBA31-R7) expressing BCSP31 was transduced into S. typhimurium X4064 to serve as a marker antigen. The ability of S. typhimurium X4064(pBA31-R7) to colonize the porcine gut-associated lymphoid tissue, liver, and spleen was determined and correlated with the induction of mucosal and systemic immune responses to the BCSP31 protein. This study demonstrates that S. typhimurium X4064 is avirulent in swine.
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MATERIALS AND METHODS Bacterial strains and plasmid. A 4.2-kb EcoRI DNA fragment has been inserted into pKK223-3 (Pharmacia, Piscataway, N.J.) to form pBA31-R7 (15) . The fragment contains the gene for a 31-kDa B. abortus protein (BCSP31). Plasmid pBA31-R7 has been transduced into S. typhimurium X4064 (Acya Acrp) (kindly provided by R. Curtiss III, Washington University, St. Louis, Mo.) to form S. typhimurium X4064(pBA31-R7) as described previously (22) .
Animals. All animals used in these experiments were 5-to 6-week-old, crossbred swine acquired from H & K Enterprises, Ames, Iowa. Animals were maintained in large isolation units with concrete floors and automatic waterers. Steam heat and exhaust fans were controlled separately for each room. Animals were fed a commercial feed containing 16% protein without antibiotic supplementation.
Antigen preparations. Purified BCSP31 was obtained from E. coli (1, 22) and designated rBCSP31. S. typhimurium x4064(pBA31-R7) soluble antigen was prepared as described previously (21, 22) . S. typhimurium X4064 endotoxin was extracted by a butanol-water method (18) .
Experimental design. The studies were conducted in multiple experiments, of which the results from three separate experiments are represented. In the first and second experiments, swine received a single oral dose of S. typhimurium x4064(pBA31-R7) (1 x 1010 to 2 x 1010 CFU per animal).
The first experiment determined invasion, colonization, and persistence of the live recombinant organism. The second experiment measured (i) serum and intestinal antibody responses to rBCSP31 and salmonella endotoxin and (ii) splenic and mesenteric lymph node (MLN) blastogenic responses. Animals in the third experiment were immunized by the protocols listed in Table 1 . The third experiment measured (i) delayed-type hypersensitive, (ii) peripheral blood lymphocyte blastogenic, and (iii) salivary antibody responses. Immunization of swine. On the day of oral immunization, animals were denied feed until 30 min after oral inoculation. Stomach acidity was neutralized with 25 ml of 10% sodium bicarbonate administered orally 5 min prior to a 50-ml oral dose of S. typhimurium (4 x 108 cells per ml). Oral doses were administered by gastric intubation, using a 40-cm flexible tube.
Inocula for primary and secondary oral immunizations were prepared from log-phase cultures of S. typhimurium X4064(pBA31-R7). Luria-Bertani (LB) broth (12) cultures (5 ml/tube) were inoculated with cells from frozen stocks (-70°C) and incubated overnight at 37°C without shaking. Overnight cultures were diluted 1:20 in prewarmed LB broth and incubated for 4 h with shaking (260 rpm at 37°C) to obtain log-phase growth. Cultures were then put on ice to inhibit further replication. The cell suspension was pelleted (8,000 x g for 10 min at 40C) and then resuspended in 0.01 M phosphate-buffered saline, pH 7.2, to its original volume.
Primary and secondary parenteral immunizations were administered intramuscularly (i.m.) and contained 1 mg of recombinant BCSP31 (rBCSP31) incorporated in Freund incomplete adjuvant (FIA). A single i.m. injection with 1 mg of rBCSP31 in saline was administered 7 days prior to the induction of a subcutaneous (s.c.) delayed-type hypersensitivity (DTH) reaction.
Invasion, colonization, and persistence studies. Groups of five pigs were sacrificed on days 2, 7, 10, 14, and 21 post-oral inoculation with S. typhimurium X4064(pBA31-R7) (2 x 1010 CFU/pig). Portions of spleen, liver, and MLN were removed from each animal and homogenized as described previously (22) . In addition, a 2-cm tissue section was removed from small-intestinal sites located 2, 14, and 26 cm from the ileal-cecal junction. The inner luminal surface of each section was scraped and homogenized (22) . Homogenates were plated on MacConkey agar containing 100 ,ug of ampicillin per ml and incubated for 24 h at 370C. Ampicillin-resistant colonies were then biochemically identified as S. typhimurium (5, 6 In a separate experiment, whole blood was collected on day 59 post-primary immunization from swine in groups A, B, D, and F (Table 1) . Peripheral blood lymphocytes were isolated by using Histopaque 1077 (Sigma) gradients. Peripheral blood lymphocytes were diluted in RPMI 1640 containing 1% fetal calf serum and plated in triplicate in 96-well microtiter plates (2.5 x 105 cells per well). Purified BCSP31 (12.5 ,ug/well) was added, and the plates were incubated for 72 h at 37°C in 5% CO2 in air. At 54 h, cells were pulsed with
[3H]thymidine and harvested as described above.
RESULTS
Colonization of swine with recombinant S. typhimurium X4064. S. typhimurium X4064(pBA31-R7) colonization of small intestine and MLN occurred rapidly, within 2 days after oral inoculation (2.0 x 105 and 1.2 x 105 cells per g of tissue, respectively), with clearance by day 10 to 14 ( Fig. 1 ). Spleen and liver were not colonized by the recombinant S. typhimurium X4064. A single oral dose of 2 x 1010 CFU/pig caused no mortality or morbidity. Swine given the same dose but on multiple occasions (days 1, 3, and 5) also showed no signs of mortality and only slight morbidity as indicated by temporary lethargy.
Serum, intestinal, and salivary antibody responses. Parenteral immunization with rBCSP31 or salmonella endotoxin stimulated a strong serum antibody response (data not shown). Swine orally immunized with S. typhimurium X4064(pBA31-R7) (experiment 2) developed serum antibodies to rBCSP31 and S. typhimurium X4064 endotoxin. Peak anti-rBCSP31 IgG and IgM titers occurred by day 14 p.i. No anti-rBCSP31 serum IgA was detected (Fig. 2A) . The serum antibody response to endotoxin consisted of IgG, IgM, and IgA isotypes. IgM and IgA peak responses developed between 7 and 14 days p.i., while a much larger IgG response peaked at day 21 p.i.
Swine orally infected with S. typhimurium X4064(pBA31-R7) showed peak intestinal IgA responses to rBCSP31 and S. typhimurium X4064 endotoxin on days 28 and 7 of infection, respectively (Fig. 3) . No intestinal IgG or IgM titers were detected against either antigen (Fig. 3) . Multiple oral doses of S. typhimurium X4064(pBA31-R7) (2 x 
cells per dose)
given on days 1, 3, and 5 did not improve intestinal antibody titers to rBCSP31 or S. typhimurium X4064 endotoxin over that obtained with a single oral dose (data not shown).
There was no detectable salivary antibody to rBCSP31 as late as 42 days post-oral immunization with S. typhimurium X4064(pBA31-R7) (experiment 3). Secondary immunizations with either live S. typhimurium X4064(pBA31-R7) or rBCSP31 in FIA were also unsuccessful at stimulating a specific salivary antibody response to rBCSP31 (data not shown). Control experiments demonstrated that the ELISA reagents recognized total salivary IgA (data not shown).
DTH responses following immunization. In the various immunization regimens used to stimulate a cell-mediated response to rBCSP31, erythema, edema, and necrosis were all indicative of a positive DTH response ( (Fig. 4, group  D) . These animals received an oral dose of S. typhimurium X4064(pBA31-R7) on day 1 
DISCUSSION
The development of new vaccine strategies has been greatly enhanced by recent advances in recombinant DNA technology. Although numerous attenuated vaccine vectors capable of expressing cloned protein have been reported, little is known about the relationship between vector and host and how this specificity might affect host cellular and humoral immunity. Since the importance of host-specific salmonella vectors in the development of useful live-vector vaccines remains uncertain, the immune responses to recombinant S. typhimurium X4064 (Acya Acrp), a mousederived SR-11 mutant, were determined in swine and then compared with those found previously in mice (22) .
The porcine antibody response to recombinant S. typhimurium X4064 was similar to our results obtained in mice (22) . In both studies, since B. abortus rBCSP31 is foreign to each animal, both primary and secondary responses to cloned protein could be observed. (Fig.  3A) . The trend, however, was for a gradual increase in the IgA titer, peaking at day 28 (ELISA values of >0.1 A405).
The apparent IgM response at day 42 was probably an artifact since one of three pigs showed an unusually high IgM response (0.92 A405). Swine developed strong serum and intestinal antibody responses to salmonella endotoxin ( Fig.  2B and 3B, respectively) . This strong response to endotoxin could be interpreted as an anamnestic response due to prior exposure of these animals to salmonellae. A random sampling of the swine herd indicated that the animals were negative for salmonellae as determined by rectal swabs enriched in tetrathionate broth. In addition, all tissues (i.e., intestine, spleen, MLN, and liver) from noninfected control animals were also bacteriologically negative for salmonellae. These culture results suggest that the animals were not exposed to Salmonella species prior to inoculation with the experimental strain. Swine, unlike mice, will respond to rBCSP31 with a cell-mediated immune response as measured in vivo by DTH (Table 1 ) and in vitro by lymphocyte blastogenesis (Fig. 4,  group D) . The DTH and blastogenic data indicate that the two parenteral injections with rBCSP31 in FIA are critical events for the induction of a cell-mediated response (Table 1 and Fig. 4, respectively) . One or two oral doses of live organisms were not sufficient to stimulate or prime a cellular response to rBCSP31. These conclusions were based on the inability to detect antigen-specific blastogenesis or DTH responses in pigs from group B or F (Table 1 and Fig. 4) (9, 10) . It would be of interest to isolate lamina propria lymphocytes from S. typhimurium X4064(pBA31-R7) orally inoculated swine and assay for increased lymphokine (i.e., interleukin-2) production in the presence of specific antigen (25). Perhaps the oral route of immunization has preferentially activated mucosal lymphocytes, while other lymphocyte populations (i.e., systemic) have remained quiescent (26).
Our studies indicate that in swine S. typhimurium X4064 (pBA31-R7) invades and colonizes only the intestine and MLN (Fig. 1) as opposed to the spleen, liver, MLN, and intestine of mice (22) . Reed Although rBCSP31 in FIA was capable of stimulating cell-mediated immune responses in swine, rBCSP31 cloned into S. typhimurium X4064 was not able to induce a detectable cellular response following one or two oral inoculations. It is possible that more sensitive techniques (i.e., interleukin-2 clonal expansion) would have detected sensitized T-cell populations in orally immunized pigs. The poor cellular immune response may be due to suboptimal levels of cloned antigen expression in vivo. Murine studies have shown plasmid pBA31-R7 to be stable in S. typhimurium X4064(pBA31-R7) (data not shown); the percentage of the bacteria that express rBCSP31 in vivo was not determined. The DTH response may depend on the degree of systemic tissue replication of the vector. Although presentation of rBCSP31 by S. typhimurium X4064(pBA31-R7) has been reported previously not to induce a DTH response in mice (22) , the fact that the organism colonizes deep tissues in mice leaves open the possibility that expression of a different protein would induce the desired DTH response.
Since S. typhimurium X4064(pBA31-R7) does not colonize the spleen or liver of swine, a more invasive vector such as S. choleraesuis may be required to test the hypothesis that tissue replication is necessary for cell-mediated immunity to cloned BCSP31. Preliminary data from our laboratory suggest that recombinant S. choleraesuis is capable of stimulating a cell-mediated response to cloned protein (rBCSP31 
